Family cascade screening may identify unaffected BRCA1/2-mutation carriers with an increased lifetime risk of 40–80 % for BC (Antoniou et al. 2003; Chen and Parmigiani 2007; King et al. 2003). This evidence concerns the gene BRCA1 and breast cancer.